The CMA investigated alleged excessive and unfair prices for phenytoin sodium capsules under Chapter II of CA98.
Marketing
Phenytoin sodium capsules: suspected unfair pricing
Source: GOV.UK Competition Markets — UK Open Government Licence v3.0